Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response

16 references·7 citing·44 second hop

FromToDepth

this work references cited by second hop

References

2005Oxytocin increases trust in humans3,690 cited
2005Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans1,639 cited
2004Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication1,059 cited
2005Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala804 cited
2001Chapter 21 Like mother, like daughter: evidence for non-genomic transmission of parental behavior and stress responsivity455 cited
2001CNS Region-Specific Oxytocin Receptor Expression: Importance in Regulation of Anxiety and Sex Behavior446 cited
1988Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography442 cited
2002Naturally Occurring Differences in Maternal Care are Associated with the Expression of Oxytocin and Vasopressin (V1a) Receptors: Gender Differences415 cited
1996An Anxiolytic Action of Oxytocin is Enhanced by Estrogen in the Mouse328 cited
1975Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophyseal system322 cited
2006Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications319 cited
1994High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats254 cited
1997Physiological and Endocrine Effects of Social Contact

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

251 cited

2002Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist211 cited

1983Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat206 cited

1997Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study203 cited

Cited by

2012Childhood aggression, callous-unemotional traits and oxytocin genes104 cited
2016Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder91 cited
2019Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis88 cited
2011Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm: Peripheral vs Central Administration87 cited
2011Vasopressin selectively impairs emotion recognition in men79 cited
2012The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor‐Binding Profile, Prosocial Effects and Distribution of c‐Fos Expression in Adolescent Rats73 cited
2012Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males71 cited